Be part of
what's next.

CYTO365 is improving the Oncology treatments with RondelO™ IV-set. Help us reach investors during the tournament — every share matters.

We are developing the Next leap for Oncology treatments with RondelO™ IV-set that reduce the risk of drug mixing, and avoids exposure risk for the nurses.

RondelO™ IV-set is regarded as the "Golden Standard" - a new standard takes time to implement and it requires dedicated investors time and funding.

Everyone knows someone that have been treated for Cancer - lets help out to help the nurses and to help the patients.